Catalyst Pharmaceuticals
CPRX
#3891
Rank
A$3.84 B
Marketcap
$32.24
Share price
-4.17%
Change (1 day)
56.63%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): A$0.13 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are A$0.43 Billion. In 2023 the company made an earning of A$0.14 Billion a decrease over its 2022 earnings that were of A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.13 B-6.28%
2023 A$0.14 B-9.75%
2022 A$0.16 B98.83%
2021 A$81.69 M25.73%
2020 A$64.98 M25.38%
2019 A$51.82 M-198.25%
2018 -A$52.75 Million84.68%
2017 -A$28.57 Million1.88%
2016 -A$28.04 Million-10.68%
2015 -A$31.39 Million30.46%
2014 -A$24.06 Million27.6%
2013 -A$18.86 Million198.17%
2012 -A$6.33 Million-36.22%
2011 -A$9.92 Million59.52%
2010 -A$6.22 Million-44.68%
2009 -A$11.24 Million-31.45%
2008 -A$16.39 Million155.21%
2007 -A$6.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.60 B 318.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$96.52 M-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.53 B 19,560.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.43 Billion-390.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.89 Billion-1,395.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.51 B 7,144.32%๐Ÿ‡บ๐Ÿ‡ธ USA